What are the preoperative factors that can determine the presence of metastases in other axillary nodes in breast cancer when the sentinel node is positive?

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 53, Issue 4, 2009, Pages 422-427

  Domenech A ^a   Benitez A ^a   Bajen M T ^a   Ricart, Y ^a   Rodriguez Gasen A ^a   Palacin J A ^a   Catala I ^a   Gil, M ^b   Pernas, S ^b   Garcia A ^a   Martin Comin J ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

Breast neoplasms; Neoplasm metastasis; Sentinel lymph node biopsy

Indexed keywords

NANOCOLL TC 99M;

ADULT; AGED; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GRADING; CONFERENCE PAPER; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; PREOPERATIVE PERIOD; SENTINEL LYMPH NODE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BREAST NEOPLASMS; HUMANS; INCIDENCE; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; SPAIN;

EID: 74949093574     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (27)

1. Giulano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15: 2345-50.
2. Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 1997;3:336-40.
3. Borgstein PJ, Pijpers R, Comans EF, Van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186:275-83.
4. Beechey-Newman N. Sentinel node biopsy: a revolution in the surgical management of breast cancer? Cancer Treat Rev 1998;24:185-203.
5. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C et al. The sentinel node in breast cancer. A multicenter validation study. N Engl J Med 1998;339:941-6.
6. Veronesi U, Paganelli G, Viale G, Galimberti V, luini A, Zurrida S et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series. J Natl Cancer Inst 1999;91:368-73.
7. Bass SS, Cox CE, Ku NN, Berman C, Reintgen DS. The role of sentinel lymph node biopsy in breast cancer. J Am Coll Surg 1999;189:183-94.
8. Hung WK, Chi-Mui Chan M, Mak KL, Chong SF, Lau Y, Ho CM et al. Non-sentinel lymph node metastases in breast cancer patients with metastatic sentinel nodes. J Surg 2005;75:27-31.
9. Weiser MR, Montgomery LL, Tan LK, Susnik B, Leung DY, Borgen PI et al. Lymphovascular invasion enhances the prediction of non-sentinel node metastases in breast cancer patients with positive sentinel nodes. Ann Surg Oncol 2001;8:145-9.
10. Reynolds C, Misk R, Donohue JH, Grant CS, Farley DR, Callans LS et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 1999;17:1720-6.
11. Turner RR, Chu KU, Qi K, Botnick LE, Hansen NM, Glass EC et al. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node. Cancer 2000;89:574-81.
12. Cserni G. Sentinel lymph node biopsy based prediction of further breast cancer metastases in the axilla. Eur J Surg Oncol 2001;27:532-8.
13. Hwang RF, Krishnamurthy S, Hunt K, Mirza N, Ames FC, Feig B et al. Clininopathologic factors predicting involvement of nonsentinel axillary nodes in women with breast cancer. Ann Surg Oncol 2003;98:2307-15.
14. Pernas S, Urruticoechea A, Benítez A, Bajen MT, Pisa A, Pla MJ et al. Is axillary dissection necessary for breast cancer patients with micrometastases in the sentinel lymph node? 5th European Breast Cancer Conference, Nice, March 2006.
15. Bajen MT, Benítez A, Mora J, Ricart Y, Ferran N, Guirao S et al. Subnormal reinjection: a method to increase surgical detection of the sentinel node in breast cancer without increasing the false-negative rate. Eur J Nucl Med Mol Imaging 2006;33:338-43.
16. Domènech A, Benítez A, Bajen MT, Pla MJ, Gil M, Martín-Comín J. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study up to 5 years. Oncology 2007;72:27-32.
17. Viale G, Maiorano E, Pruneri G, Mastropasqua M, Valentini S, Galimberti V et al. Predicting the risk of additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsy. Ann Surg 2005;241:319-25.
18. Fleming FJ, Kavanagh D, Crotty TB, Quinn CM, McDermott EW, O'Higgins N et al. Factors affecting metastases to non-sentinel lymph nodes in breast cancer. J Clin Pathol 2004;57:73-6.
19. Wada N, Imoto S, Yamauchi C, Hasebe T, Ochiai A. Predictors of tumour involvement in remaining axillary lymph nodes of breast cancer patients with positive sentinel lymph node. EJSO 2006;32:29-33.
20. Chu KU, Turner RR, Hansen NM, Brennan MB, Bilchnik A, Giulano AE. Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis. Ann Surg Oncol 1999;6:756-61.
21. Kamath VJ, Giulano R, Dauway EL, Cantor A, Berman C, Ku NN et al. Characteristics of the sentinel lymph node in breast cancer predict further involvement of higher-echelon nodes in the axilla: a study to evaluate the need for complete axillary lymph node dissection. Arch Surg 2001;136:688-92.
22. Rahusen FD, Torrenga H, Van Diest PJ, Pijpers R, Van der Wall E, Licht J et al. Predictive factors for metastatic involvement of non-sentinel nodes in patients with breast cancer. Arch Surg 2001;136:1059-63.
23. Nos C, Harding-MacKean C, Freneaux P, Trie A, Falcou MC, Sastre-Garau X et al. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. Br J Surg 2003;90:1354-60.
24. Wong SL, Edwards MJ, Chao C, Tuttle TM, Noyes RD, Woo C et al. Predicting the status of the nonsentinel axillary nodes: a multicenter study. Arch Surg 2001;136:563-8.
25. Goyal A, Douglas-Jones A, Newcombe RG, Mansel RE. Predictors of non-sentinel lymph node metastasis in breast cancer patients. Eur J Cancer 2004;40:1731-7.
26. Abdessalam SF, Zervos EE, Prasad M, Farrar WB, Yee LD, Walker MJ et al. Predictors of positive axillary lymph nodes after sentinel lymph node biopsy in breast cancer. Am J Surg 2001;182:316-20.
27. Tan LGL, Tan YY, Heng D, Chan MY. Predictors of axillary lymph node metastases in women with early breast cancer in Singapore. Singapore Med J 2005;46:693.